We are live on
!
Find out more
Verition Fund Management Portfolio holdings
AUM
$15.4B
1-Year Est. Return
30.69%
This Fund
S&P 500
This Quarter
Est. Return
+2%
1 Year Est. Return
+30.69%
3 Year Est. Return
+85.73%
5 Year Est. Return
+92.38%
10 Year Est. Return
+282.97%
AUM
$7.23B
AUM Growth
+$828M
(+13%)
Cap. Flow
-$307M
Cap. Flow
% of AUM
-4.25%
Top 10 Holdings %
Top 10 Hldgs %
10.7%
Holding
2,791
New
730
Increased
583
Reduced
470
Closed
679
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$53M |
| 2 |
NextEra Energy
NEE
|
+$52.3M |
| 3 |
CenterPoint Energy
CNP
|
+$42.7M |
| 4 |
NiSource
NI
|
+$38.8M |
| 5 |
Exelon
EXC
|
+$36.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
US Bancorp
USB
|
+$47.9M |
| 2 |
AstraZeneca
AZN
|
+$38.7M |
| 3 |
GFLU
GFL Environmental Inc. Tangible Equity Units
GFLU
|
+$35.7M |
| 4 |
VMW
VMware, Inc
VMW
|
+$32.4M |
| 5 |
PCGU
PG&E Corporation
PCGU
|
+$30.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 12.25% |
| 2 | Industrials | 9.66% |
| 3 | Utilities | 9.48% |
| 4 | Technology | 8.06% |
| 5 | Healthcare | 7.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PLAO
726
DELISTED
Patria Latin American Opportunity Acquisition Corp. Class A Ordinary Shares
PLAO
| $1.33M | 0.02% |
126,413
| – | – |
|
727
Imperial Oil
IMO
$62.7B
| $1.32M | 0.02% |
+26,059
| New | +$1.3M |
|
728
Dillards
DDS
$9.19B
| $1.32M | 0.02% |
4,298
+3,385
| +371% | +$1.2M |
|
729
Intuitive Surgical
ISRG
$127B
| $1.32M | 0.02% |
5,175
+2,174
| +72% | +$536K |
|
730
Five Below
FIVE
$12B
| $1.32M | 0.02% |
6,393
+1,074
| +20% | +$212K |
|
731
Walt Disney
DIS
$167B
| $1.31M | 0.02% |
13,080
-27,528
| -68% | -$2.78M |
|
732
PUT
Intel
INTC
$455B
| $1.31M | 0.02% |
+40,000
| New | +$1.13M |
|
|
SUM
733
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
| $1.3M | 0.02% |
+45,750
| New | +$1.38M |
|
|
SGEN
734
DELISTED
Seagen Inc. Common Stock
SGEN
| $1.3M | 0.02% |
+6,416
| New | +$1.03M |
|
|
DALS
735
DELISTED
DA32 Life Science Tech Acquisition Corp. Class A Common Stock
DALS
| $1.3M | 0.02% |
128,120
| – | – |
|
736
SLB Ltd
SLB
$73.6B
| $1.3M | 0.02% |
26,385
-4,470
| -14% | -$237K |
|
737
PUT
Moderna
MRNA
$21.8B
| $1.29M | 0.02% |
8,400
| – | – |
|
738
3M
MMM
$90.9B
| $1.29M | 0.02% |
14,664
+10,245
| +232% | +$966K |
|
739
Sprouts Farmers Market
SFM
$8.13B
| $1.29M | 0.02% |
36,786
+26,428
| +255% | +$855K |
|
740
Simon Property Group
SPG
$74.4B
| $1.29M | 0.02% |
11,504
+1,914
| +20% | +$229K |
|
741
APA Corp
APA
$13.2B
| $1.28M | 0.02% |
35,630
+24,055
| +208% | +$965K |
|
742
Designer Brands
DBI
$307M
| $1.28M | 0.02% |
146,889
-29,990
| -17% | -$288K |
|
743
Destination XL Group
DXLG
$31.2M
| $1.28M | 0.02% |
+231,740
| New | +$1.47M |
|
744
Clean Harbors
CLH
$16.5B
| $1.28M | 0.02% |
8,956
+4,881
| +120% | +$636K |
|
745
Texas Capital Bancshares
TCBI
$4.3B
| $1.27M | 0.02% |
+25,948
| New | +$1.59M |
|
746
Sprinklr
CXM
$1.49B
| $1.27M | 0.02% |
+97,770
| New | +$991K |
|
747
Freeport-McMoran
FCX
$90B
| $1.27M | 0.02% |
30,948
+6,994
| +29% | +$291K |
|
748
IQVIA
IQV
$38.7B
| $1.26M | 0.02% |
6,334
+4,052
| +178% | +$866K |
|
749
iShares MBS ETF
MBB
$38.9B
| $1.26M | 0.02% |
+13,287
| New | +$1.25M |
|
750
GitLab
GTLB
$5.83B
| $1.25M | 0.02% |
+36,519
| New | +$1.6M |
|
Similar funds
RFC
NMO
EH
OAC
UM
EF
Verition Fund Management's Q1 2023 Portfolio in Review
As of Q1 2023, Verition Fund Management held 2,791 positions worth $7.23B, up 13% from $6.4B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Verition Fund Management withdrew a net $307M in Q1 2023, closing 679 positions and reducing 470 holdings. Its most notable exit was AstraZeneca, an estimated $38.7M position sold in full.
By sector, the portfolio is most concentrated in Financials at 12% of assets, down from 13% a quarter earlier, followed by Industrials and Utilities.
Against the trend, Verition Fund Management opened a new position in Jacobs Solutions worth $33.6M.
- Verition Fund Management's largest Q1 2023 buy was Jacobs Solutions: 346,045 shares worth $33.6M.
- Verition Fund Management added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2023, an estimated $53M increase.
- Verition Fund Management's biggest Q1 2023 reduction was US Bancorp, cutting an estimated $47.9M.
- Verition Fund Management fully exited AstraZeneca in Q1 2023, selling an estimated $38.7M.
- Verition Fund Management's ten largest holdings make up 11% of its $7.23B portfolio in Q1 2023.
- Verition Fund Management opened 730 new positions and closed 679 in Q1 2023.
- Verition Fund Management's portfolio value rose 13% quarter-over-quarter to $7.23B.
Based on Verition Fund Management's 13F filing for Q1 2023, filed 15 May 2023.